Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Overweight 1Obesity 1Motor Activity 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Endometrial Neoplasms 1Disease 1Depressive Disorder 1Depression 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Modafinil 9Methylphenidate 4Saline Solution 3regorafenib 2Sugars 2Physical Therapy Modalities 2Exercise 2Dexamethasone 2reparixin 1ofatumumab 1epoetin beta 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1clazakizumab 1caffeine, sodium benzoate drug combination 1Yoga 1Walking 1Waiting Lists 1Vinorelbine 1Urinalysis 1Therapeutics 1Thalidomide 1Testosterone 1Sodium Chloride 1Proton Pump Inhibitors 1Patient Reported Outcome Measures 1Megestrol Acetate 1Lenalidomide 1Lactose 1Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fatigue × Counseling × Clear all
NCT01410942 2026-02-20

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
175 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡